Lipid Metabolism in Tumor-Associated Fibroblasts
- PMID: 33740247
- DOI: 10.1007/978-981-33-6785-2_8
Lipid Metabolism in Tumor-Associated Fibroblasts
Abstract
Tumor- or cancer-associated fibroblasts (TAFs), one of the most abundant stromal cell types in various carcinomas, consist of a heterogeneous cell population. Typically, TAFs are assigned with pro-tumor activities to promote tumor growth and progression. One of the key features of solid tumors is the metabolic reprogramming that induces alterations of bioenergetics and biosynthesis in both tumor cells and TAFs. Therefore, this review emphasizes TAFs lipid metabolism related to both TAFs differentiation process and TAFs crosstalk with cancer cells. We hope that this review will help understand lipid metabolism in tumor microenvironment, and support the rational design of metabolism-based approaches to improve the efficacy of cancer therapy.
Keywords: Cancer cells; Lipid metabolism; Metabolism; Tumor microenvironment; Tumor-associated fibroblasts.
Similar articles
-
Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.Biomed Res Int. 2018 Jun 5;2018:6075403. doi: 10.1155/2018/6075403. eCollection 2018. Biomed Res Int. 2018. PMID: 29967776 Free PMC article. Review.
-
Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy.Cancer Lett. 2019 Apr 28;448:31-39. doi: 10.1016/j.canlet.2019.01.032. Epub 2019 Feb 5. Cancer Lett. 2019. PMID: 30731107 Free PMC article. Review.
-
Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.Oncotarget. 2016 Dec 13;7(50):82324-82337. doi: 10.18632/oncotarget.10327. Oncotarget. 2016. PMID: 27384989 Free PMC article.
-
Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.Theranostics. 2021 Jul 13;11(17):8322-8336. doi: 10.7150/thno.62378. eCollection 2021. Theranostics. 2021. PMID: 34373744 Free PMC article. Review.
-
Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.Mol Pharm. 2021 Aug 2;18(8):2889-2905. doi: 10.1021/acs.molpharmaceut.1c00455. Epub 2021 Jul 14. Mol Pharm. 2021. PMID: 34260250 Free PMC article. Review.
Cited by
-
Dietary fat and lipid metabolism in the tumor microenvironment.Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188984. doi: 10.1016/j.bbcan.2023.188984. Epub 2023 Sep 16. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37722512 Free PMC article. Review.
-
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.Int J Nanomedicine. 2024 Jan 18;19:571-608. doi: 10.2147/IJN.S442877. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260239 Free PMC article. Review.
-
Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments.Ann Transl Med. 2021 Aug;9(15):1237. doi: 10.21037/atm-21-3026. Ann Transl Med. 2021. PMID: 34532374 Free PMC article.
-
Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes.Front Oncol. 2023 May 15;13:1144430. doi: 10.3389/fonc.2023.1144430. eCollection 2023. Front Oncol. 2023. PMID: 37256178 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical